Emilsson A and Sundler R |
Differential activation of phosphatidylinositol deacylation and a pathway via diphosphoinositide in macrophages responding to zymosan and ionophore A23187. |
1984 |
J. Biol. Chem. |
pmid:6321496
|
Mueller HW et al. |
1-O-alkyl-linked glycerophospholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. |
1984 |
J. Lipid Res. |
pmid:6427378
|
Hillmar I et al. |
Effects of a thio analog of platelet-activating factor on platelet aggregation and adenosine 3',5'-monophosphate concentration in hepatocyte suspensions and in platelets. A comparison with the naturally occurring compound. |
1984 |
Hoppe-Seyler's Z. Physiol. Chem. |
pmid:6325321
|
Valone FH |
Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine. |
1984 |
Immunology |
pmid:6325330
|
Cervoni P et al. |
Evidence for the lack of interaction between (+/-)-1-O-octadecyl-2-acetylglyceryl-3-phosphorylcholine and alpha-adrenoceptors in vivo and in vitro. |
1984 |
Br. J. Pharmacol. |
pmid:6091835
|
Fink KL and Gross RW |
Modulation of canine myocardial sarcolemmal membrane fluidity by amphiphilic compounds. |
1984 |
Circ. Res. |
pmid:6091941
|
Goldenberg MM and Meurer RD |
A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat. |
1984 |
Prostaglandins |
pmid:6505225
|
Wissner A et al. |
Analogues of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain. |
1984 |
J. Med. Chem. |
pmid:6471071
|
Mallet AI et al. |
Rapid isocratic high-performance liquid chromatographic purification of platelet activating factor (PAF) and lyso-PAF from human skin. |
1984 |
J. Chromatogr. |
pmid:6480761
|
Kenzora JL et al. |
Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs. |
1984 |
J. Clin. Invest. |
pmid:6480824
|
Jackson EM et al. |
High performance liquid chromatography of platelet-activating factors. |
1984 |
J. Lipid Res. |
pmid:6481248
|
Smith RJ et al. |
Stimulation of the human neutrophil superoxide anion-generating system with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3- phosphorylcholine. |
1984 |
Biochem. Pharmacol. |
pmid:6324816
|
Dewar A et al. |
Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig. |
1984 |
J. Pathol. |
pmid:6481526
|
Goldstein BM et al. |
Effect of platelet activating factor (PAF) on blood flow distribution in the spontaneously hypertensive rat. |
1984 |
Life Sci. |
pmid:6482659
|
Baldo BA and Tovey ER |
Allergy, allergens and allergen standardization. |
1984 |
Med. J. Aust. |
pmid:6482786
|
Saeki S et al. |
Effect of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine on blood pressure by intra-lateral ventricular injection in the rat. |
1984 |
Med J Osaka Univ |
pmid:6482814
|
Nishizawa EE and Della-Coletta AA |
The formation of a thrombin-like material (TLM) following stimulation of leukocytes. |
1984 |
Thromb. Res. |
pmid:6484896
|
Buxton DB et al. |
Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine. |
1984 |
J. Biol. Chem. |
pmid:6693418
|
Ostermann G et al. |
Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. |
1984 |
Thromb. Res. |
pmid:6710440
|
Levi R et al. |
Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig. |
1984 |
Circ. Res. |
pmid:6692502
|
Humphrey DM et al. |
Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. |
1984 |
Lab. Invest. |
pmid:6694349
|
Masugi F et al. |
Effect of 1-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the rat. |
1984 |
Life Sci. |
pmid:6694519
|
Bottecchia D et al. |
Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation. |
1984 |
Scand J Haematol |
pmid:6695148
|
Blank ML et al. |
A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6696762
|
Williams KA and Haslam RJ |
Effects of NaCl and GTP on the inhibition of platelet adenylate cyclase by 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (synthetic platelet-activating factor). |
1984 |
Biochim. Biophys. Acta |
pmid:6696908
|
Hoffman DR et al. |
Cytotoxicity of platelet activating factor and related alkyl-phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblasts. |
1984 |
Blood |
pmid:6696992
|
McGivern DV and Basran GS |
Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man. |
1984 |
Eur. J. Pharmacol. |
pmid:6592097
|
Beaubien BB et al. |
Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6594998
|
Roubin R et al. |
The role of immunomodulators in the production of lipid mediators by macrophages (M phi). |
1984 |
Int J Tissue React |
pmid:6596298
|
Archer CB et al. |
Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin. |
1984 |
Br. J. Dermatol. |
pmid:6581831
|
Archer CB et al. |
Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man. |
1984 |
Prostaglandins |
pmid:6203139
|
Schlondorff D et al. |
Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells. |
1984 |
J. Clin. Invest. |
pmid:6423667
|
Bult H et al. |
Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells. |
1984 |
Agents Actions Suppl. |
pmid:6382974
|
Hechtman HB et al. |
Role of humoral mediators in adult respiratory distress syndrome. |
1984 |
Chest |
pmid:6383742
|
Kelton JG et al. |
The detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura. |
1984 |
Ann. Intern. Med. |
pmid:6333196
|
Bussolino F et al. |
Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines. |
1984 |
Exp. Hematol. |
pmid:6333353
|
Wodzinowska B and Krajewski T |
[Role of blood platelets and their membrane in the process of hemostasis]. |
1984 Jan-Feb |
Postepy Hig Med Dosw |
pmid:6093087
|
Vemulapalli S et al. |
Cardiovascular and renal action of platelet-activating factor in anesthetized dogs. |
1984 Jul-Aug |
Hypertension |
pmid:6378787
|
Cox CP et al. |
VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). |
1984 Mar-Apr |
Peptides |
pmid:6206481
|
Page CP et al. |
Platelets and asthma. |
1985 |
Lancet |
pmid:2857401
|
Gresele P et al. |
Platelets and asthma. |
1985 |
Lancet |
pmid:2857402
|
Matsumoto M and Miwa M |
Platelet-activating factor-binding protein in human serum. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004155
|
Terashita Z et al. |
Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004156
|
Barnes JL and Venkatachalam MA |
The role of platelets and polycationic mediators in glomerular vascular injury. |
1985 |
Semin. Nephrol. |
pmid:2957770
|
Leid RW and Potter KA |
Inflammation and mediators of lung injury. |
1985 |
Vet. Clin. North Am. Food Anim. Pract. |
pmid:3907779
|
Shukla SD |
Platelet activating factor-stimulated formation of inositol triphosphate in platelets and its regulation by various agents including Ca2+, indomethacin, CV-3988, and forskolin. |
1985 |
Arch. Biochem. Biophys. |
pmid:3875314
|
Roubin R and Benveniste J |
Formation of prostaglandins, leukotrienes and paf-acether by macrophages. |
1985 |
Comp. Immunol. Microbiol. Infect. Dis. |
pmid:3910339
|
Billah MM et al. |
Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. |
1985 |
Prostaglandins |
pmid:3936121
|
Wasserman SI |
Mast cell mediators in the blood of patients with asthma. |
1985 |
Chest |
pmid:3880526
|
Halonen M et al. |
Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. Effects of PGI2 inhibition of platelet function. |
1985 |
Am. Rev. Respir. Dis. |
pmid:3881060
|
Sybertz EJ et al. |
Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:3917504
|
Harlan JM |
Leukocyte-endothelial interactions. |
1985 |
Blood |
pmid:3918593
|
McKean ML and Silver MJ |
Phospholipid biosynthesis in human platelets. The acylation of lyso-platelet-activating factor. |
1985 |
Biochem. J. |
pmid:3919710
|
Archer CB et al. |
Actions of disodium cromoglycate (DSCG) on human skin responses to histamine, codeine and Paf-acether. |
1985 |
Agents Actions |
pmid:3923788
|
Sturk A et al. |
Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. |
1985 |
Thromb. Res. |
pmid:2934863
|
Morley J et al. |
Pharmacology of the late response to allergen and its relevance to asthma prophylaxis. |
1985 |
Int. Arch. Allergy Appl. Immunol. |
pmid:3924841
|
Hwang SB et al. |
Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. |
1985 |
Lab. Invest. |
pmid:3925239
|
Valone FH and Johnson B |
Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine. |
1985 |
J. Immunol. |
pmid:2578151
|
Bourgain RH et al. |
The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. |
1985 |
Prostaglandins |
pmid:3931178
|
Camussi G et al. |
The role of platelet-activating factor in experimental immune complex pathology. |
1985 |
Int J Tissue React |
pmid:2932406
|
Benveniste J |
Biosynthesis and function of PAF-acether (platelet-activating factor). |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936197
|
Waku K et al. |
Metabolism of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a precursor of platelet-activating factor in macrophages. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936199
|
Saito K et al. |
Determination of AGEPC generated from human neutrophils and rat skin and muscle tissues by a selected ion monitoring technique of GC/MS. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936200
|
Hanahan DJ et al. |
Platelet-activating factor: a unique lipid chemical mediator. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936201
|
Zimmerman GA et al. |
Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. |
1985 |
Circulation |
pmid:3928193
|
O'Neill C |
Partial characterization of the embryo-derived platelet-activating factor in mice. |
1985 |
J. Reprod. Fertil. |
pmid:4067921
|
Darius H et al. |
Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:2997428
|
Chesney CM et al. |
Desensitization of human platelets by platelet activating factor. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3977920
|
Nakayama R et al. |
Generation of acetyl glyceryl ether phosphorylcholine from the rat skin and muscle tissues stimulated by moxibustion. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3977939
|
Archer CB et al. |
Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. |
1985 |
Br. J. Dermatol. |
pmid:3978036
|
Gerdin B et al. |
Permeability-increasing ability of PAF-acether in rat skin. |
1985 |
Inflammation |
pmid:3980073
|
Emeis JJ and Kluft C |
PAF-acether-induced release of tissue-type plasminogen activator from vessel walls. |
1985 |
Blood |
pmid:3924144
|
Aul C et al. |
[Thrombotic thrombocytopenic purpura]. |
1985 |
Klin. Wochenschr. |
pmid:4038757
|
Hanahan DJ et al. |
A novel approach to structure proof of glyceryl ether-containing glycerophospholipids. Base-catalyzed methanolysis of platelet-activating factor (AGEPC) at 60 degrees C. |
1985 |
J. Lipid Res. |
pmid:4067422
|
Atkins JN |
Platelet-aggregating factor in thrombotic thrombocytopenic purpura. |
1985 |
Ann. Intern. Med. |
pmid:4038861
|
Cordón-Cardó C |
[The barley cell or mastocyte: cellular and molecular biology]. |
1985 |
Med Clin (Barc) |
pmid:2580196
|
Klöcking HP et al. |
Release of tissue-type plasminogen activator by platelet-activating factor. |
1985 |
Thromb. Res. |
pmid:4040278
|
Pedersen AK and FitzGerald GA |
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing. |
1985 |
Clin. Pharmacol. Ther. |
pmid:3917387
|
McManus LM and Pinckard RN |
Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit. |
1985 |
Am. J. Pathol. |
pmid:4050977
|
Disselnkötter H et al. |
[Synthesis of phosphono analogs of 2-O-acetyl-1-O-hexadecyl(octadecyl)-sn-3-glycerylphosphorylcholine (platelet-activating factor)]. |
1985 |
Arch. Pharm. (Weinheim) |
pmid:4051690
|
Robinson M and Snyder F |
Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species. |
1985 |
Biochim. Biophys. Acta |
pmid:4052436
|
Page CP et al. |
Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. |
1985 |
Agents Actions |
pmid:4003195
|
Page CP et al. |
Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. |
1985 |
Agents Actions |
pmid:4003196
|
Spicer BA et al. |
An investigation of the involvement of platelet activating factor in the non-histamine immediate hypersensitivity reaction in the rat peritoneal cavity. |
1985 |
Agents Actions |
pmid:4003197
|
Sandler RM et al. |
Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet-aggregating IgG. |
1985 |
Am. J. Clin. Pathol. |
pmid:4003343
|
Tencé M et al. |
Ether-phospholipid composition in neutrophils and platelets. |
1985 |
Thromb. Res. |
pmid:4024039
|
Oda M et al. |
Production of platelet-activating factor by washed rabbit platelets. |
1985 |
J. Lipid Res. |
pmid:3934305
|
Tan EL and Snyder F |
Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue. |
1985 |
Thromb. Res. |
pmid:4024051
|
O'Flaherty JT |
Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE. |
1985 |
J. Cell. Physiol. |
pmid:2981891
|
Khan SN et al. |
Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins. |
1985 |
Eur. J. Pharmacol. |
pmid:3920056
|
Bushfield M et al. |
Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. |
1985 |
Biochem. J. |
pmid:3002327
|
Johnson HM and Torres BA |
Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon. |
1985 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:2412225
|
Fjellner B and Hägermark O |
Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. |
1985 |
Acta Derm. Venereol. |
pmid:2416164
|
Shen TY et al. |
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. |
1985 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:2983307
|
Avdonin PV and Altukhova IP |
[Blocking with phorbol ester, a protein kinase C activator, of receptor-dependent platelet calcium channels]. |
1985 |
Biokhimiia |
pmid:2416359
|
Pannocchia A and Hardisty RM |
Cyclic AMP inhibits platelet activation independently of its effect on cytosolic free calcium. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2983714
|
Lee TD et al. |
Heterogeneity in mast cell populations. |
1985 |
Clin Immunol Rev |
pmid:2417770
|
Leclercq M et al. |
[Effects of Hymenoptera stings: physiopathology and immunology according to recent literature findings]. |
1985 |
Rev Med Liege |
pmid:2418479
|
Pipili E |
Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density. |
1985 |
Thromb. Haemost. |
pmid:2418525
|
Nishihira J et al. |
Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets. |
1985 |
Tohoku J. Exp. Med. |
pmid:3001971
|